Breast Cancer (Dove Med Press)
December 2023
A novel and rapid therapeutic approach is the treatment of human breast cancer by enhancing the host's immune system. In initial findings, program death one (PD-1) and program cell death ligand one (PD-L1) showed positive results towards solid tumors, but tumor relapse and drug resistance are the major concerns. Breast cancer therapy has been transformed by the advent of immune checkpoint blockades (ICBs).
View Article and Find Full Text PDFHydrolysis of phosphate groups is a crucial reaction in living cells. It involves the breaking of two strong bonds, i.e.
View Article and Find Full Text PDF